Intended for healthcare professionals

Rapid response to:

News

Public’s distrust of medicines needs urgent action, says academy

BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j2974 (Published 20 June 2017) Cite this as: BMJ 2017;357:j2974

Rapid Response:

Re: Public’s distrust of medicines needs urgent action, says academy

Public is correct in distrusting medicines, according to mainstream academic research data.
FDA approves and allows marketing drugs often based on weak evidence. [1]
"Indispensable flu medication" in eventually downgraded by WHO. [2]
Flawed research conclusions induced US opioid addiction crisis. [3]
Widely prescribed statins in older people are useless for primary prevention. [4]
Cheap chondroitin sulfate is as effective as the widely prescribed expensive non-steroidal anti-inflammatory drug (NSAID) celecoxib for treating painful knee osteoarthritis. [5]
Corticosteroid injections for painful knee osteoarthritis produce no benefit and might even be harmful to cartilage. [6]
Levothyroxine should no longer be prescribed in elderly patients with subclinical hypothyroidism. [7]
These referenced conclusions arose after reviewing clinical publications on the BMJ appeared online only during the last 2 months.
Who can accuse patients of being skeptical about commonly prescribed pharmaceuticals, after this?
References
[1] http://www.bmj.com/content/357/bmj.j2905
[2] http://www.bmj.com/content/357/bmj.j2841
[3] http://www.bmj.com/content/357/bmj.j2741
[4] http://www.bmj.com/content/357/bmj.j2486
[5] http://www.bmj.com/content/357/bmj.j2515
[6] http://www.bmj.com/content/357/bmj.j2386
[7] http://www.bmj.com/content/357/bmj.j1754

Competing interests: No competing interests

20 June 2017
Stavros Saripanidis
Consultant in Obstetrics and Gynecology
Kalamaria, Thessaloniki, Greece